COMMUNIQUÉS West-GlobeNewswire

Evn Introduces a Game-Changer in Cannabis Edibles with New Hemp-Derived Live Resin Gummies
08/03/2024
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Evn , a pioneering company in the hemp industry, has just announced the launch of its groundbreaking product – Hemp-derived Live Resin Gummies . Each pouch is bursting with [...]
InkSpace Imaging makes their advanced MRI coils available to Siemens Healthineers Magnetom Scanners
08/03/2024
PLEASANTON, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging proudly announces a major leap forward in advancing diagnostic imaging capabilities. Today, the company revealed the successful certification of [...]
Wegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease
08/03/2024
Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy ® based on a supplemental New Drug Application (sNDA) for the [...]
Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program
08/03/2024
The competitive Department of Defense “Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Translational Research Award” will fund preclinical development of Biosplice’s DYRK inhibitors in [...]
EssilorLuxottica: 2023 Universal Registration Document filed
08/03/2024
2023 Universal Registration Document filed Charenton-le-Pont, France (March 8, 2024 – 6:30 pm) – EssilorLuxottica announces the availability of its 2023 Universal Registration Document, in accordance with applicable [...]
EssilorLuxottica: Mise à disposition du Document d’enregistrement universel 2023
08/03/2024
Mise à disposition du Document d’enregistrement universel 2023 Charenton-le-Pont, France (8 mars 2024 – 18h30) – EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2023 dans les [...]
NeuroOne® to Participate in the 36th Annual Roth Conference
08/03/2024
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
MEDIA ADVISORY: New Report on Ottawa clinic exposes the “Wild West” created by Ontario’s rush to for-profit health care
08/03/2024
Attn: Assignment Editor OTTAWA, March 08, 2024 (GLOBE NEWSWIRE) -- A new report to be released Friday contains shocking revelations about the ownership and management behind private health clinics in Ottawa. Based on a [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
08/03/2024
Company announcement – No. 13 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, March [...]
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
08/03/2024
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company [...]
Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting
08/03/2024
KT-621 (STAT6) and KT-294 (TYK2) have the potential to provide biologics-like activity with oral small molecule profiles KT-621 (STAT6) expected to start Phase 1 in second half of 2024 and KT-294 (TYK2) expected to [...]
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
08/03/2024
Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT [...]
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2023
08/03/2024
Montrouge, France, le 8 mars 2024 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2023 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société [...]
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
08/03/2024
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & [...]
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
08/03/2024
WINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the Bioscience Association of Manitoba (“BAM”) annual awards [...]
Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting
08/03/2024
- Cerebrospinal fluid (CSF) biomarker results are highly supportive of sabirnetug’s downstream pharmacological effects in the brain in early AD - Poster presentation showcases method used to develop a first-of-its-kind [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
08/03/2024
Please see enclosed pdf. Attachment 08032024_trading_in_shares_LRA
Teladoc Health to Participate in Upcoming Investor Conference
08/03/2024
PURCHASE, NY, March 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief [...]
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
08/03/2024
Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy. [...]

Pages